Share this
Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion
Biotech Company ViaCyte to Be Acquired by Vertex Pharmaceuticals
Bristol Myers Squibb to Acquire Turning Point Therapeutics for $4.1 Billion
Nykode Therapeutics Enters Collaboration Agreement with Regeneron
Neurocrine Biosciences Enters Collaboration Agreement with Sosei Heptares
Vividion Therapeutics Agrees to Sell to Bayer for up to $2 Billion
Horizon Therapeutics to Acquire Viela Bio
Artiva: $78 Million Series A Financing
Neurocrine Partners With Takeda to Address Psychiatric Disorders
Horizon Pharma Buys River Vision for $145 Million and Unspecified Earn-Out
Horizon Pharma Acquisition of Crealta Holdings for $510 Million
Auspex Pharma $3.5 billion sale to Teva Pharma
Horizon Pharma Completes $400 Million Exchangeable Senior Notes Offering
Ambit Biosciences to be Acquired by Daiichi Sankyo for $410 Million
Horizon Pharma Acquires Vidara Therapeutics and Enters Five-Year $300 Million Term Loan Facility
Horizon Pharma $660 Million Acquisition of Vidara Therapeutics